Tools
Tools
Hargreaves, IP and Mantle, D (2018) Vitamin K2 supplementation in haemodialysis patients. Journal of Kidney Care, 3 (6). ISSN 2397-9534
|
Text
Vitamin K2 supplementation in haemodialysis patients.pdf - Accepted Version Download (272kB) | Preview |
Publisher URL: http://dx.doi.org/10.12968/jokc.2018.3.6.368
Abstract
Many patients with end-stage renal disease who are undergoing haemodialysis also have cardiovascular disease. In this article, Ian Hargreaves and David Mantle review the potential role of vitamin K2 supplementation in reducing arterial calcification, and therefore cardiovascular mortality, in haemodialysis patients
| Item Type: | Article |
|---|---|
| Additional Information: | This document is the Accepted Manuscript version of a Published Work that appeared in final form in Journal of Kidney Care, copyright © MA Healthcare, after peer review and technical editing by the publisher. To access the final edited and published work see http://dx.doi.org/10.12968/jokc.2018.3.6.368 |
| Subjects: | R Medicine > RM Therapeutics. Pharmacology |
| Divisions: | Pharmacy & Biomolecular Sciences |
| Publisher: | Mark Allen Group |
| Date Deposited: | 03 Apr 2019 10:12 |
| Last Modified: | 04 Sep 2021 09:38 |
| DOI or ID number: | 10.12968/jokc.2018.3.6.368 |
| URI: | https://researchonline.ljmu.ac.uk/id/eprint/10322 |
 |
View Item |